Mesothelioma - Intravascular injection of thorium dioxide (Thorotrast) Factor
Last reviewed for CCPS 15 October 2008.
Preliminary questions [40285]
40299 [1] there is some evidence that an intravascular injection of thorium dioxide (Thorotrast) may be a factor in the development of the condition under consideration.
40300 [1] the veteran has had an intravascular injection of thorium dioxide (Thorotrast) at some time.
40301 [2] the veteran had an intravascular injection of thorium dioxide (Thorotrast) for treatment of an illness or injury which is identifiable. 40302 — the veteran has established the causal connection between an intravascular injection of thorium dioxide (Thorotrast) and VEA service for the clinical onset of mesothelioma. 40304 — the veteran has established the causal connection between an intravascular injection of thorium dioxide (Thorotrast) and eligible service for the clinical onset of mesothelioma. or 40303 — the veteran has established the causal connection between an intravascular injection of thorium dioxide (Thorotrast) and operational service for the clinical onset of mesothelioma. Clinical onset and operational service [40303] 40307 — the identified illness or injury, for which the veteran had the intravascular injection of thorium dioxide (Thorotrast), is causally related to operational service. [4] [5] Clinical onset and eligible service [40304]
40308 — the identified illness or injury, for which the veteran had the intravascular injection of thorium dioxide (Thorotrast), is causally related to eligible service. [8] [5]
Links
[1] https://clik.dva.gov.au/ccpsb044rc
[2] clikpopup://CCPS/Intravascular injection of thorotrast for identifiable illness or injury
[3] clikpopup://CCPS/reject40301No
[4] clikpopup://CCPS/reject40305No
[5] clikpopup://CCPS/reject40307,40308No
[6] clikpopup://CCPS/Intravascular injection of thorotrast for identified illness 15 years before onset of mesothelioma
[7] clikpopup://CCPS/reject40306No
[8] clikpopup://CCPS/reject40308No